Bausch + Lomb has bought the assets and U.S. rights for Zirgan from Sirion Therapeutics. Zirgan is a topical anti-viral used to treat acute herpetic keratitis, or corneal ulcers, a condition that often results in corneal transplants. It is caused by the herpes simplex virus, and recurs repeatedly, leading to ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.